NEW YORK (GenomeWeb) – A federal court this week preliminarily approved an agreement in which Celera will pay former shareholders $23 million to settle a five-year-old lawsuit that alleged the company made materially false and misleading financial statements, inflating its stock price. 

As part of the decision handed down on Tuesday by the US District Court for the Northern District of California, co-defendant PriceWaterhouseCoopers has also agreed to pay $1.75 million to settle the litigation. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.